Cyclophosphamide potentiates the antitumor activity of v-p97NY

This publication has 12 references indexed in Scilit:

• Characterization of a recombinant vaccinia virus expressing human melanoma-associated antigen p97
  Journal of Virology, 1988
• Immunotherapy of murine sarcomas with auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells.
  The Journal of Immunology, 1987
• Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells.
  The Journal of Experimental Medicine, 1986
• T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity.
  The Journal of Experimental Medicine, 1986
• Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.
  The Journal of Experimental Medicine, 1985
• General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes
  Journal of Virology, 1984
• Regression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population.
  The Journal of Experimental Medicine, 1978
• Cyclophosphamide delays 3-methylcholanthrene sarcoma induction in mice
  Nature, 1978
• Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes
  The Journal of Experimental Medicine, 1977